Table 3. Univariate and multivariate Cox regression analysis of clinical factors for OS in gastric cancer with peritoneal carcinomatosis.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
HR | 95%CI | P value | HR | 95%CI | P value | |
Age | 0.98 | 0.93-1.02 | 0.21 | |||
Gender | 0.74 | 0.36-1.49 | 0.13 | |||
Tumor grade | 0.35 | 0.12-1.02 | 0.05* | 0.48 | 0.15-1.48 | 0.20 |
T stage | 1.46 | 0.59-3.59 | 0.41 | |||
N stage | 1.11 | 0.34-3.68 | 0.86 | |||
Status of metastatic site | 2.32 | 1.12-4.81 | 0.02* | 2.32 | 1.11-4.86 | 0.02* |
Previous Surgery | 0.93 | 0.39-2.16 | 0.87 | |||
Adjuvant chemotherapy | 1.07 | 0.43-2.61 | 0.89 | |||
Chemotherapy regimens | 0.90 | 0.36-2.23 | 0.82 | |||
Chemotherapy cycle number ( < 4cycles VS > 4 cycles) | 0.30 | 0.13-0.68 | 0.004* | 0.24 | 0.09-0.60 | 0.002* |
Endostar | 2.63 | 1.16-5.97 | 0.02* | 2.42 | 1.04-5.63 | 0.04* |
HR, hazard ratio; CI, confidence interval; VS, versus, *p<0.05 statistically significant.